RECRUITINGINTERVENTIONAL

Church-based Health Intervention to Eliminate Racial Inequalities in Cardiovascular Health

About This Trial

Cardiovascular disease (CVD) is the leading cause of death in the US general population. Although CVD mortality rates declined for both Black and White populations during the past two decades, they are still higher in Black adults than White adults. There are also persistent disparities in CVD risk factors with higher prevalence of obesity, hypertension, and diabetes in Black compared to White populations. In addition, CVD and risk factors are more prevalent in the residents of Louisiana compared to the US general population. The Church-based Health Intervention to Eliminate Racial Inequalities in Cardiovascular Health (CHERISH) study will use a church-based community health worker (CHW)-led multifaceted intervention to address racial inequities in CVD risk factors in predominantly Black communities in New Orleans, Louisiana. The primary aim of the CHERISH study is to compare the impact of two implementation strategies - a CHW-led multifaceted strategy and a group-based education strategy - for delivering interventions recommended by the 2019 American College of Cardiology (ACC)/American Heart Association (AHA) Guideline on the Primary Prevention of Cardiovascular Disease on implementation and clinical effectiveness outcomes in predominantly Black church community members over 18 months.

Who May Be Eligible (Plain English)

Who May Qualify: - Men or women aged ≥40 years - Community members associated with the participating churches (church members and their families and friends) - Individuals with three or more CVD risk factors (out of seven): - Current smoker - Overweight or obese (BMI ≥25 kg/m2) - Insufficient physical activity (\<150 minutes/week moderate intensity or \<75 minutes/week vigorous intensity) - Healthy diet score of \<4 components - Total cholesterol ≥200 mg/dL - Blood pressure ≥130/80 mmHg - Fasting plasma glucose ≥100 mg/dL - Willing and able to participate in the intervention Who Should NOT Join This Trial: - No prior hospitalization in the last 3 months for chronic heart failure or heart attack. - No current diagnosis of cancer requiring chemotherapy or radiation therapy - No stage-5 chronic kidney disease requiring chronic dialysis, or transplant. - Not pregnant or planning to become pregnant in the next 18 months. - No plans to move out of the New Orleans metropolitan area during the next year. Always talk to your doctor about whether this trial is right for you.

Original Eligibility Criteria

View original clinical language

Inclusion Criteria: * Men or women aged ≥40 years * Community members associated with the participating churches (church members and their families and friends) * Individuals with three or more CVD risk factors (out of seven): * Current smoker * Overweight or obese (BMI ≥25 kg/m2) * Insufficient physical activity (\<150 minutes/week moderate intensity or \<75 minutes/week vigorous intensity) * Healthy diet score of \<4 components * Total cholesterol ≥200 mg/dL * Blood pressure ≥130/80 mmHg * Fasting plasma glucose ≥100 mg/dL * Willing and able to participate in the intervention Exclusion Criteria: * No prior hospitalization in the last 3 months for chronic heart failure or heart attack. * No current diagnosis of cancer requiring chemotherapy or radiation therapy * No stage-5 chronic kidney disease requiring chronic dialysis, or transplant. * Not pregnant or planning to become pregnant in the next 18 months. * No plans to move out of the New Orleans metropolitan area during the next year.

Treatments Being Tested

BEHAVIORAL

Evidence-based interventions recommended by the 2019 ACC/AHA Guideline on the Primary Prevention of CVD

The recommended evidence-based interventions include therapeutic lifestyle change and medical treatment of hypertension, diabetes, and hypercholesterolemia.

Locations (1)

Tulane University

New Orleans, Louisiana, United States